Royal KPN N.V.:企業の戦略・SWOT・財務情報

◆英語タイトル:Royal KPN N.V. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C6962
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:技術・通信
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Royal KPN N.V. – Strategy, SWOT and Corporate Finance Report
Summary

Royal KPN N.V. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Royal KPN NV (KPN) provides telecommunications, and information and communication technology (ICT) services. The company provides consulting, broadband services, mobile telephony, ICT solutions, voice termination and data services. It also provides wholesale network services, voice and data services through its global subsidiary, iBasis. Major brands of the company include XS4ALL, Simyo, Telfort, Ortel Mobile, iBasis, KPN, Cam IT solutions, Solcon and Divider. KPN provides services in the areas of communication, information, entertainment, and commercial sectors. It serves to residential, businesses and corporate customers. The company has business presence in the Netherlands, UK, Belgium and the Americas. KPN is headquartered in Hague, the Netherlands.

Scope

- Detailed information on Royal KPN N.V. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Royal KPN N.V. in the form of a SWOT analysis
- An in-depth view of the business model of Royal KPN N.V. including a breakdown and examination of key business segments
- Intelligence on Royal KPN N.V.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Royal KPN N.V., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Royal KPN N.V. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Royal KPN N.V. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Royal KPN N.V.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Royal KPN N.V.: Company Overview 9
Royal KPN N.V.: Overview and Key Facts 9
Royal KPN N.V.: Overview 9
Royal KPN N.V.: Key Facts 9
Royal KPN N.V.: Key Employees 11
Royal KPN N.V.: Key Employee Biographies 12
Royal KPN N.V.: Major Products and Services 14
Royal KPN N.V.: Company History 15
Royal KPN N.V.: Management Statement 23
Royal KPN N.V.: Locations and Subsidiaries 26
Royal KPN N.V.: Key Competitors 27
Royal KPN N.V.: Company Analysis 28
Royal KPN N.V.: Business Description 28
Royal KPN N.V.: SWOT Analysis 32
Royal KPN N.V.: SWOT Overview 32
Royal KPN N.V.: Strengths 32
Royal KPN N.V.: Weaknesses 33
Royal KPN N.V.: Opportunities 33
Royal KPN N.V.: Threats 34
Royal KPN N.V.: Corporate Financial Deals Activity 36
Royal KPN N.V.: Financial Deals Overview 36
Royal KPN N.V.: Targets and Partners 37
Royal KPN N.V.: Top Deals 2014 – 2018YTD* 38
Royal KPN N.V.: Advisors 39
Royal KPN N.V.: Top Financial Advisors 39
Royal KPN N.V.: Mergers and Acquisitions 40
Royal KPN N.V.: Divestments 41
Royal KPN N.V.: Recent Developments 42
Royal KPN N.V.: News and Events Summary 42
Royal KPN N.V.: Business Expansion 44
Royal KPN N.V.: Corporate Governance 44
Royal KPN N.V.: Financial Deals 45
Royal KPN N.V.: Financial Performance 46
Royal KPN N.V.: Research & Development 46
Appendix 48
Contact Us 48
Methodology 48
About MarketLine 49

List of Tables
Table 1: Royal KPN N.V.: Key Facts
Table 2: Royal KPN N.V.: Key Employees
Table 3: Royal KPN N.V.: Company History
Table 4: Royal KPN N.V.: Locations and Subsidiaries
Table 5: Royal KPN N.V.: Key Competitors
Table 6: Royal KPN N.V.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Royal KPN N.V.: M&A Average Deal Size - Value (US$m)
Table 8: Royal KPN N.V.: Targets and Partners
Table 9: Royal KPN N.V.: Top Deals 2014 - 2018YTD*
Table 10: Royal KPN N.V.: Financial Advisor Ranking by Value (US$m)
Table 11: Royal KPN N.V.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 12: Royal KPN N.V.: M&A Activity by Geography (2014 - YTD*2018)
Table 13: Royal KPN N.V.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 14: Royal KPN N.V.: Divestments by Geography (2014 - YTD*2018)
Table 15: Royal KPN N.V.: News and Events Summary
Table 16: Royal KPN N.V.: Business Expansion
Table 17: Royal KPN N.V.: Corporate Governance
Table 18: Royal KPN N.V.: Financial Deals
Table 19: Royal KPN N.V.: Financial Performance
Table 20: Royal KPN N.V.: Research & Development

List of Figures
Figure 1: Royal KPN N.V.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Royal KPN N.V.: M&A Average Deal Size - Value (US$m)
Figure 3: Royal KPN N.V.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 4: Royal KPN N.V.: M&A Activity by Geography (2014 - YTD*2018)
Figure 5: Royal KPN N.V.: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 6: Royal KPN N.V.: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Royal KPN N.V.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Senhwa Biosciences Inc (6492)-製薬・医療分野:企業M&A・提携分析
    Summary Senhwa Biosciences Inc (Senhwa) is a drug development company that develops small molecule drugs for the treatment of cancer. The company’s products include CX-5461 and CX-4945. Its CX-5461 is a p53 activating Pol I inhibitor and anticancer compound for treating hematological malignancies. S …
  • Kadimastem Ltd (KDST):企業の財務・戦略的SWOT分析
    Summary Kadimastem Ltd (Kadimastem) is a clinical stage biopharmaceutical company that develops industrial regenerative medicines to treat neuro-degenerative diseases. Its technology platform enables the manufacturing of islet-like endocrine cells (differentiated cells) and glia restricted progenito …
  • Kentucky Power Co:企業の発電所・SWOT分析2018
    Kentucky Power Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Kyokuyo Co., Ltd.:企業の戦略・SWOT・財務分析
    Kyokuyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kyokuyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Astellas Pharma Inc.:企業の戦略・SWOT・財務情報
    Astellas Pharma Inc. - Strategy, SWOT and Corporate Finance Report Summary Astellas Pharma Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Hycor Biomedical Inc-医療機器分野:企業M&A・提携分析
    Summary Hycor Biomedical Inc (Hycor) is a medical device company that manufactures and markets in-vitro diagnostic products. The company offers products such as auto immune testing systems, allergy testing systems, HYTEC plus and HYCOR ultrasensitive EIA products. Its auto immune testing products co …
  • Oasmia Pharmaceutical AB (OASM):製薬・医療:M&Aディール及び事業提携情報
    Summary Oasmia Pharmaceutical AB (Oasmia Pharmaceutical) is a pharmaceutical company that develops drugs for human and veterinary oncology. The company’s product portfolio consists of animal health products that include doxophos vet and paccal vet and human health products which include doxophos, pa …
  • XBiotech Inc (XBIT):企業の財務・戦略的SWOT分析
    Summary XBiotech Inc (XBiotech) is a biopharmaceutical company that discovers, develops and commercialize therapeutic antibodies based proprietary technology. The company provides monoclonal antibodies treatment for various diseases. It’s lead product Xilonix, a therapeutic antibody being developed …
  • Dusit Thani Public Company Limited:戦略・SWOT・企業財務分析
    Dusit Thani Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Dusit Thani Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • China National Offshore Oil Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary China National Offshore Oil Corp (CNOOC) carries out exploration, development, and production of crude oil and natural gas. The company also offers engineering and technical services, including oilfield, offshore oil engineering, and professional services. It is also involved in the producti …
  • Rapiscan Systems, Inc.:戦略・SWOT・企業財務分析
    Rapiscan Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Rapiscan Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Sensus Healthcare Inc (SRTS):製品パイプライン分析
    Summary Sensus Healthcare Inc (Sensus), previously Sensus Healthcare LLC, designs, manufactures, and markets proprietary medical devices for the treatment of various types of cancers and skin diseases. The company offers superficial radiation therapy (SRT) technology based non-surgical treatment opt …
  • Banca IFIS SpA:企業の戦略・SWOT・財務情報
    Banca IFIS SpA - Strategy, SWOT and Corporate Finance Report Summary Banca IFIS SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • HCL Technologies Ltd (HCLTECH):企業の財務・戦略的SWOT分析
    HCL Technologies Ltd (HCLTECH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Zurich Insurance Group Ltd:企業の戦略・SWOT・財務情報
    Zurich Insurance Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Zurich Insurance Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • PT Paninvest Tbk:企業の戦略・SWOT・財務情報
    PT Paninvest Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Paninvest Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Telephone and Data Systems, Inc.:企業の戦略・SWOT・財務情報
    Telephone and Data Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Telephone and Data Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Red Electrica Corporacion, SA (REE):電力:M&Aディール及び事業提携情報
    Summary Red Electrica Corporacion, SA (REC), together with its subsidiaries undertakes electricity transmission and system operation and management of the transmission network for the Spanish electricity system. The company carries out the regulated activities through its principal subsidiary, Red E …
  • Isagen SA ESP:企業の戦略的SWOT分析
    Isagen SA ESP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Independent News & Media PLC (IPDC):企業の財務・戦略的SWOT分析
    Independent News & Media PLC (IPDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆